Rose-Hulman Institute of Technology Raises Over $250 Million to Empower STEM Education

The Mission Driven Campaign for Rose-Hulman expanded student and academic services.an

Rose-Hulman: Mussallem Union

Rose-Hulman Institute of Technology

The Mission Driven Campaign for Rose-Hulman has supported student scholarships, new educational spaces, faculty support, and global/diversity initiatives.

The Mission Driven Campaign for Rose-Hulman has transformed our campus and prepared us to better meet the challenges of being a top STEM college focused on undergraduate education.”

— Robert A. Coons, President, Rose-Hulman Inst. of Tech.

TERRE HAUTE, IN, UNITED STATES, July 29, 2021 /EINPresswire.com/ — Rose-Hulman Institute of Technology has successfully achieved a $250 million comprehensive fundraising campaign that has helped increase student scholarships, brought new learning spaces to campus, and solidified its position as a national leader in undergraduate science, technology, engineering, and mathematics (STEM) education.

The Mission Driven Campaign for Rose-Hulman has brought substantial support in the following areas:
• $127 million for student scholarships and financial aid.
• $81 million for the Fund for Rose-Hulman.
• $30 million for new spaces to expand networking and learning; and
• $12 million for faculty support, global and diversity initiatives.

The campaign raised $50 million over the past year alone and more than $100 million since 2018.

“The Mission Driven Campaign for Rose-Hulman has transformed our campus and prepared us to better meet the challenges of being a top STEM college focused on undergraduate education,” said Rose-Hulman President Robert A. Coons. “We’re grateful for the commitment by so many in support of providing our students with the world’s best undergraduate STEM education in an environment of individual attention and support.”

Coons noted that to remain at the forefront of STEM higher education, Rose-Hulman needed to recruit and retain leading-edge faculty and staff, attract academically strong students throughout the world from a wide range of socioeconomic and ethnic groups, modernize facilities and equipment, and stay ahead of technological change. Other key strategic goals were continuing to increase retention and expansion of hands-on experiences for students that are giving them an edge in the job market and graduate school applications.

Significantly increased student scholarships throughout the campaign helped drive enrollment among students, including those from diverse socioeconomic, ethnic, and cultural backgrounds. Recent examples include:
• Alumnus and Board of Trustees chair Niles Noblitt and his wife, Nancy, established the Noblitt Scholars program with a $10 million gift.
• Linda and Mike Mussallem, an alumnus and trustee, added a $4.1 million scholarship gift supporting students from northwest Indiana and the Chicagoland area.

Additional gifts supported the creation and expansion of key spaces and programs on campus.
• A $15 million lead gift from a donor helped pave the way to build a new $29 million, 70,000-square-foot academic building, opening for the 2021-22 school year;
• More than $16 million from Lilly Endowment, Inc. supporting several Rose-Hulman initiatives such as Ask Rose Homework Hotline, PRISM, ESCALATE, and Mindful Connections.
• A $10.5 million gift from Linda and Mike Mussallem paved the way for the $21 million expansion of the institute’s Mussallem Union, dedicated in May 2018.
• The 13,800-square-foot Richard J. and Shirley J. Kremer Innovation Center, opened during the 2018-19 school year, expanded opportunities for students to enhance their hands-on, collaborative educational experiences.

“These new workspaces, laboratories and classrooms provide our faculty with the tools to in turn provide our students with the skills desired by industry throughout the world and the nation’s leading graduate and doctorate programs,” said Jeffrey A. Harrison, president and chief executive officer of Citizens Energy Group in Indianapolis, who served as the campaign co-chair with Thomas Dinkel, president of Terre Haute-based Sycamore Engineering. Both are Rose-Hulman alumni and trustees.

Additionally, the proceeds from the campaign supported the installation of new synthetic turf, creating two multipurpose fields used for athletics, recreation and intramural activities. The auction of a McLaren P1 hypercar owned by alumnus Felda Hardymon brought in a world-record $2.39 million, which supported the endowment of the Alfred R. Schmidt Chair for Excellence in Teaching, reinforcing the development of transformative learning experiences in the classroom.

Rose-Hulman also has expanded academic programs in data science, engineering design, biomathematics, and international studies during the Mission Driven Campaign.

Steve Brady, vice president for institutional advancement, noted that the campaign received financial support from many groups, including alumni, friends, corporations, foundations, faculty, staff, and parents. This broad-based support helped Rose-Hulman surpass its ambitious fundraising goal, even within the challenges of the recent COVID-19 pandemic.

“Our supporters were driven to help us achieve our campaign goal,” Brady said. “Our alumni value their Rose-Hulman experiences and all of the elements that went into their educations, including our dedicated, caring and talented faculty and staff. They wanted to make sure the institute remained on the cutting edge and, most importantly, a leading force in undergraduate STEM education.”
Rose-Hulman is consistently recognized nationally as an elite STEM school for distinctions that include faculty excellence, return on investment, value-added, and career services.

Coons adds that the success of the Mission Driven Campaign is guiding Rose-Hulman toward its future. “Administrators, faculty and staff are already examining short-term and long-range strategic initiatives for the future. Some of those goals will be announced later this year.”
“Rose-Hulman is a place that continues to evolve and improve to meet the challenges of higher education’s changing landscape,” said the president.

About Rose-Hulman Institute of Technology
Founded in 1874, Rose-Hulman Institute of Technology is dedicated to preparing its students with the world’s best undergraduate science, engineering and mathematics education in an environment infused with innovation, intellectual rigor and individualized attention. The institute is consistently recognized nationally as an elite STEM school for distinctions that include faculty excellence, return on investment, value-added, and career services. Career placement is near 100 percent year after year. Located in Terre Haute, Indiana, Rose-Hulman has an enrollment of approximately 2,000 undergraduate students and nearly 100 graduate students. Learn more at rose-hulman.edu.

INTERVIEW AVAILABILITY
Rose-Hulman President Robert Coons is available for on-campus, Zoom or telephone interviews. Make arrangements through Dale Long, director of media relations, at dale.long@rose-hulman.edu or 812-877-8418.

IMAGE ATTACHMENT DESCRIPTION:
Here is a link to a Dropbox with images showcasing successful areas of the Mission Driven Campaign for Rose-Hulman: https://www.dropbox.com/sh/qtw714ezju7u1ai/AADEu5SoIYsr1FcY31TqvKfYa/Photos?dl=0&subfolder_nav_tracking=1
Please credit: Rose-Hulman Institute of Technology/Bryan Cantwell

ROSE-HULMAN B-ROLL VIDEO:
Video showcasing areas of Rose-Hulman’s campus impacted by areas of the Mission Driven Campaign for Rose-Hulman can be found at the following Dropbox:
https://www.dropbox.com/sh/qtw714ezju7u1ai/AABr3V6qr9o6GyMuSasTus9Aa/Video?dl=0&preview=Rose-Hulman+Mission+Driven+Video+v3.mp4&subfolder_nav_tracking=1
Any portion of this b-roll segment can be used with this news release.

Dale Long
Rose-Hulman Institute of Technology
+1 812-877-8418
dale.long@rose-hulman.edu
Visit us on social media:
Facebook

Rose-Hulman Media B-roll Video


Source: EIN Presswire

Pharmaceutical Sterility Testing Industry Players Are Working On Increasing Presence In Market with Product Innovation

Pharmaceutical Sterility Testing Market Report 2021: COVID-19 Growth And Change To 2030

Pharmaceutical Sterility Testing Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Pharmaceutical Sterility Testing Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, July 29, 2021 /EINPresswire.com/ — Companies in the pharmaceutical testing market are increasing new pharmaceutical sterility testing products and services to enhance their product portfolio and increase their presence in the market. The companies are launching technologically superior outcomes and well-equipped services to utilize the growth potential of the rising pharmaceutical sterility market. For instance, in 2019, RSSL started a sterility testing service for pharmaceutical and medical device companies, which gives fast, active, and flexible test services. RSSL’s new sterility testing service includes two methods, membrane filtration for aqueous, ethanol, solution, and oil-based products and direct injection tests for non-soluble products, to determine the presence of infecting microorganisms in sterilized or aseptic drug products. Similarly in October 2019, Alcami Corporation, a leading provider of a fully integrated system for pharmaceutical and biologics industries, launched a new rapid sterility offering, a service that leverages cutting-edge microbiological testing technology to give significantly faster-testing returns to customers.

Major players in the pharmaceutical sterility testing market are Pacific Biolabs, STRERIS Corporation, Boston Analytical, Gibraltar Laboratories, Sartorius AG, SolviasAG, SGS AG, Toxikon, Inc., Pace Analytical Services LLC and Charles River Laboratories International Inc.

In August 2018, Sotera Health, a USA based pharmaceutical company, acquired Gibraltar Laboratories for an undisclosed amount. The acquisition is expected to expand the business of analytical testing capabilities of Sotera Health’s Nelson Labs. Gibraltar Laboratories is an external provider of microbiological and analytical chemical tests that includes sterilization services for pharmaceutical and medical device manufacturers.

Read More On The Global Pharmaceutical Sterility Testing Market Report:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testing-market-global-report-2020-30-covid-19-impact-and-recovery

The global pharmaceutical sterility testing market size was worth $1.01 billion in 2020. The pharma sterility testing market global forecast to 2021 is to be at a compound annual growth rate (CAGR) of 10.9%. to reach $1.12 billion in 2021. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The pharmaceutical sterility testing market is expected to reach $1.69 billion in 2025 at a CAGR of 10.8%.

The pharmaceutical sterility testing market covered in this report is segmented by sample into sterile drugs, medical devices, biologics and therapeutics. The pharmaceutical sterility testing market is also segmented by product type into instruments, kits and reagents, services; by type into in- house, outsourcing; by test type into sterility testing, bioburden testing, bacterial endotoxin testing and by end-user into compounding pharmacies, medical devices companies, pharmaceutical companies.

Pharmaceutical Sterility Testing Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides pharmaceutical sterility testing market overview, forecast pharmaceutical sterility testing market size and growth for the whole market, pharmaceutical sterility testing market segments, and geographies, pharmaceutical sterility testing market trends, pharmaceutical sterility testing market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Pharmaceutical Sterility Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2826&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Pharma Microbiology Testing Kits Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/pharma-microbiology-testing-kits-global-market-report

Sterilization Equipment and Disinfectants Market – By Type Of Products (Sterilization Equipment, Disinfectants), By Method (Physical Method, Chemical Method, Mechanical Method), By End User (Hospitals And Clinics, Clinical Laboratories, Pharmaceutical Companies, Other Industries, Non-Industrial Use), And By Region, Opportunities And Strategies – Global Forecast To 2023
https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-market

Hospital Acquired Infections Testing Kits Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Interested to know more about The Business Research Company?

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

High Potency APIs Industry Growth Is Driven By Rising Cancer Cases

HP (High Potency) APIs Market Report 2021: COVID-19 Growth And Change To 2030

HP (High Potency) APIs Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s HP (High Potency) APIs Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, July 29, 2021 /EINPresswire.com/ — The rising number of cancer cases coupled with increasing sales of cancer drugs contributed to the growth of the high potency APIs market. This rising incidence of cancer is resulting in increasing R&D for anticancer drugs, which in turn is propelling the demand for high potency APIs market. According to the World Health Organization’s International Agency for Research on Cancer (IARC) report published in 2018, the cancer burden is expected to increase 29.5 million new cases and 16.4 million deaths by 2040, globally. Moreover, 70% of deaths from cancer occur in middle and low-income countries. Therefore, the growing incidence of cancer cases is projected to upsurge revenues for the high potency APIs market.

The high potency APIs (HPAPI) market consists of sales of high potency active pharmaceutical ingredients and related services. High potency APIs are extremely effective in pharmacologically active ingredients. These are highly specific in their action and offer significant efficiency even at the low daily therapeutic doses. HPAPIs are used in formulations for high potent drugs, owing to their ability to target precise disease cells including cancer cells.

Read More On The Global High Potency APIs Market Report:
https://www.thebusinessresearchcompany.com/report/hp-high-potency-apis-market-global-report-2020-30-covid-19-impact-and-recovery

TBRC’s high potency APIs /HPAPI market report is segmented by type into innovative HPAPI, generic HPAPI. The high potency APIs market is also segmented by synthesis type into synthetic HPAPI, biotech HPAPI and by therapeutic application into oncology, hormonal disorder, glaucoma, other therapeutic applications (respiratory disorders, CVD, diabetes, cosmetology, and erectile dysfunction).

The global HP (High Potency) APIs market is expected to grow from $19.27 billion in 2020 to $20.3 billion in 2021 at a compound annual growth rate (CAGR) of 5.3%. The HPAPI market growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The HPAPI market size is expected to reach $27.3 billion in 2025 at a CAGR of 7.7%.

Major players in the high potency APIs market are Eli Lily and Company, Novartis AG, Bristol-Myers Squibb Company, Roche Diagnostics Ltd., Sanofi, Hospira Inc., BASF SE, Covidien plc, Boehringer Ingelheim GmbH and Merck & Co. Inc.

HP (High Potency) APIs Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides High Potency APIs Market overview, forecast High Potency APIs Market size and growth for the whole market, High Potency APIs Market segments, and geographies, High Potency APIs Market trends, High Potency APIs Market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global High Potency APIs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2814&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Pharmaceutical API Manufacturing Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/pharmaceutical-api-manufacturing-global-market-report

COVID-19 Drug Associated APIs Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-apis-market-global-report-2020-covid-19-growth-and-change

Contract Development Manufacturing Organizations Global Market Report 2021: COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/contract-development-manufacturing-organizations-global-market-report

Pharmaceutical Drugs And Biologics Logistics Market – By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbs), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-and-biologics-logistics-market

Interested to know more about The Business Research Company?

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Sterilization Equipment And Disinfectants Market Boosted By Sustainable Solutions For PPE Through COVID-19

Sterilization Equipment And Disinfectants Market Report 2021: COVID-19 Implications And Growth To 2030

Sterilization Equipment And Disinfectants Global Market Report 2021: COVID-19 Implications And Growth To 2030

The Business Research Company’s Sterilization Equipment And Disinfectants Global Market Report 2021: COVID-19 Implications And Growth To 2030

LONDON, GREATER LONDON, UK, July 29, 2021 /EINPresswire.com/ — Sustainable solutions such as repeat sterilization of medical equipment including personal protective equipment are expected to boost the market during the forecast period. As there is a shortage in the supply of PPE to the hospitals offering services to COVID-19 patients, few companies have come up with repeat sterilization of used PPE like gowns and masks. In April 2020, San-I-Pak, a California based company that manufactures equipment for high-end waste treatment, has sterilization equipment that sterilizes used medical equipment like PPE including isolation gown, 3M safety glasses, several non-branded polycarbonate glasses and surgical masks. Similarly, Battelle Memorial Institute, a non-profit research organization, is aiming at re-using the N95 respirator masks by sterilizing the N95 respirator masks as long as the masks are not made of cellulose. Battelle has been funded with $400 million by the Defense Logistics Agency under US HHS to provide decontamination of N95 across 60 sites of the USA. Following the scarcity of PPE, decontamination or sterilization of PPE rather than replacing this vital medical equipment is expected as a growth area.

The global sterilization equipment and disinfectants market is expected to grow from $9.04 billion in 2020 to $11.11 billion in 2021 at a compound annual growth rate (CAGR) of 22.9%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The disinfectants and sterilization equipment market size is expected to reach $17.54 billion in 2025 at a CAGR of 12%.

Read More On The Sterilization Equipment And Disinfectants Global Market Report:
https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-global-market-report-2021-covid-19-implications-and-growth-to-2030

Major players in the sterilization equipment and disinfectants market are 3M Company, Cantel Medical Corporation, Steris Corporation, Getinge AB, Belimed, TSO3 Inc., Matachana Group, CISA Production srl, Advanced Sterilization Products, Sakura SI CO.

The sterilization equipment and disinfectants market covered in the sterilization equipment and disinfectants market report is segmented by product type into sterilization equipment, disinfectants. It is also segmented by method into physical method, chemical method, mechanical method; by end-user into hospitals and clinics, pharmaceutical companies, clinical laboratories.

Sterilization Equipment And Disinfectants Global Market Report 2021: COVID-19 Implications And Growth To 2030 is one of a series of new reports from The Business Research Company that provides sterilization equipment and disinfectants market overview, forecast sterilization equipment and disinfectants market size and growth for the whole market, sterilization equipment and disinfectants market segments, and geographies, sterilization equipment and disinfectants market trends, sterilization equipment and disinfectants market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Sterilization Equipment And Disinfectants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4003&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Hand Sanitizers Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/hand-sanitizers-market-global-report-2020-30-covid-19-growth-and-change

Pharmaceutical Sterility Testing Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testing-market-global-report-2020-30-covid-19-impact-and-recovery

Ethyl Alcohol Global Market Report 2021: COVID-19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/ethyl-alcohol-manufacturing-global-market-report-2020-30-covid-19-implications-and-growth

Soap And Cleaning Compounds Global Market Report 2021: COVID-19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/soap-and-cleaning-compounds-global-market-report-2020-30-covid-19-impact-and-recovery

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Internet Of Things Services Market To Grow At Rate Of 24% Through 2025 With Increase In IoT Use Cases

IoT Services Market Report 2021: COVID-19 Growth And Change To 2030

IoT Services Global Market Report 2021: COVID-19 Growth And Change To 2030

IoT Services Market Report 2021: COVID-19 Growth And Change To 2030

IoT Services Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s IoT Services Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, July 29, 2021 /EINPresswire.com/ — An increase in the internet of things use cases is expected to drive the IoT service market. IoT use cases are the areas where IoT can be used for automating any process and increasing productivity. Over the years, IoT has found its use in many areas such as manufacturing, farming, smartwatches, smart cities, transportation, and other fields, which has increased the need for IoT services that provide support by delivering services such as consulting, data management, network management, security services, and others. For instance, Telit, a leading IoT enabler, provides an IoT security system that helps users to control and monitor the surveillance along with collecting data and analysing it to improve the security of buildings, turning them into smart buildings. The IoT use cases eventually increase the demand for IoT services and are expected to drive market growth.

The global IoT services market is expected grow from $139.24 billion in 2020 to $162.39 billion in 2021 at a compound annual growth rate (CAGR) of 16.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The internet of things (IoT) managed services market size is expected to reach $381.16 billion in 2025 at a CAGR of 24%.

Read More On The Global IoT Services Market Report:
https://www.thebusinessresearchcompany.com/report/iot-services-market-global-report-2020-30-covid-19-growth-and-change

The internet of things (IoT) services market consists of the sales of IoT as services and their related products. Business entities act as a support to the end-user companies by providing professional and managed services such as network management, data management platforms, infrastructure, and deployment of the IoT technology for making them automated and smarter. Internet of things (IoT) services are delivered by the IoT service providers who provide consulting, security, and analytics services as per the requirement of the business.

Major players in the internet of things (IoT) services industry are Cisco Systems, Cognizant, Google, Infosys, Tieto Corporation, Virtusa Corporation, Accenture PLC, IBM, Tech Mahindra, and Harman International Industries.

TBRC’s IoT solutions and services market report is segmented by type into professional services, managed services. Leading verticals with demand for IoT solutions are manufacturing, retail, IT & telecom, transportation & logistics, utilities, healthcare, energy, others. The report is also segmented by application into smart buildings, smart manufacturing, smart transport and logistics, smart healthcare, smart retail, smart energy.

IoT Services Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides IoT services market overview, forecast IoT services market size and growth for the whole market, IoT services market segments, and geographies, IoT services market trends, IoT services market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global IoT Services Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3261&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

IoT Security Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/iot-security-global-market-report

IoT in Manufacturing Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

IoT Enabled Healthcare Equipment Market – By Type (Diagnostic Equipment, Implanted Devices, Wearable Devices), By Country, By Company Profiles, And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/iot-enabled-healthcare-equipment-market

Interested to know more about The Business Research Company?

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

ISPMB Calls Attention to Federal Government’s Reportedly Failed Efforts to Protect Wild Horses on Public Lands

RAPID CITY, SOUTH DAKOTA, UNITED STATES, July 29, 2021 /EINPresswire.com/ — The International Society for the Protection of Mustangs and Burros (ISPMB) is calling attention this year to the United States Government’s alleged failure to properly protect wild horses on public lands. This may ultimately lead to the elimination of wild horses on these lands, according to the ISPMB in this second part of a three-part series focusing on the well-protected Heber horse herd.

According to the ISPMB, most advocates of wild horses believe the United States Forest Services and the Bureau of Land Management’s claims that wild horses need to be controlled because they are overpopulating. In fact, the Bureau of Land Management asserted to the United States Congress that the number of wild horses and burros in America grows at a rate of 20% each year and will reach more than a million by 2030, but this is a huge lie, according to the ISPMB.

The reality is, the Bureau of Land Management actually never wanted to manage wild horses and thus is pushing for the administration of birth control to wild horses on public lands, according to the ISPMB. However, the population of Arizona’s Heber herd—the only horse herd remaining undisturbed on public lands—has remained stable over the years, as its growth rate is only about 3%. Specifically, back in 2006, the population was estimated at between 300 and 400 animals, and 14 years later, in 2020, the population was 450 animals, according to the ISPMB.

The ISPMB said this herd’s existence is proof that horses can be effectively preserved on public lands without the need for birth control measures.

The ISPMB had managed four wild herds for 17 years, and a major part of its management model emphasizes the harmful effects of birth control drugs on wild horses. Instead, the ISPMB is pushing for the federal government and for the public at large to recognize the importance of enabling wild horses to maintain their natural behaviors so that they can not only survive but also thrive for years to come.

Gary Hagins
Digital Marketing
email us here


Source: EIN Presswire

Global AI in Pharma Industry Investment Digest 2021

Investment Digest 2021

Investment Digest 2021

Deep Pharma Intelligence Has Profiled and Analyzed the 2021 Global AI in Pharma Industry Investments, Covering 1200+ Companies and Investors

This Investment Digest is summarizing key players and observations in the private equity and venture capital ecosystem, focusing on the pharmaceutical Artificial Intelligence (AI)”

— Deep Pharma Intelligence

LONDON, UNITED KINGDOM, July 29, 2021 /EINPresswire.com/ — Deep Pharma Intelligence, a subsidiary of Deep Knowledge Group, releases an open-access, 80-page investment digest to provide tangible industry investment insights, market trends, and information about leading companies and investors: AI in Pharma Investment Digest Q2 2021.

Link to the Investment Digest: www.deep-pharma.tech/investment-digest
Link to the Interactive Dashboard: www.deep-pharma.tech/public-companies-dashboard

This Investment Digest summarizes key players and observations in the private equity and venture capital ecosystem, focusing on pharmaceutical artificial intelligence (AI). The information in the digest covers key industry trends, 300 promising AI-driven Pharma companies, and 50 leading investors in this sector. The report also outlines major investment rounds and relevant R&D partnerships, illustrating the industry traction and readiness of institutional investors (big pharma/biotech) to potentially acquire the most successful AI-vendors.

A number of collaborations between the Pharma Industry and AI-oriented companies have shown a steady increase in Q1–Q2 of 2021 compared to 2020. Thus, 2021 looks to be a year that will once more confirm a clear trend of increasing collaboration between Pharma and AI.
The Investment Digest identifies several major trends and insights regarding the investment landscape, R&D collaborations, and many other important factors based on a detailed examination of key market players and overall industry dynamics.

Some of the key points from the analysis include the following:

– The segment of pharmaceutical AI continues consolidation with the increasing number of later stage mega-rounds, including those of Insitro ($400M), Valo Health ($300M), Exscientia ($265M), Insilico Medicine ($255M), and others. In the AI startups pack, there is a clear distinction between the leaders, who developed substantial resources, financial leverage, and technological advantage, and others lagging behind — companies with fewer resources or less mature technology and scientific assets. The latter are usually focused on narrow therapeutic or technological niches and are following service-oriented business models.

There is an ongoing increase in investment activity in the Pharmaceutical AI sector during the first half of 2021, together with the emergence of SPAC pathways to public markets and an increasing rush among leading pharma and contract research organizations (CROs) to compete for partnerships with AI-driven companies. All this leads to the conclusion that AI technology has achieved enough maturity to be able to bring tangible value for drug discovery — far beyond a simple optimization gain.

Big pharma and contract research organizations increasingly compete for AI partnerships and continue building in-house AI workflows — driven by rapidly emerging evidence of the AI tech feasibility and innovation potential. A number of highly notable proof-of-concept results have been announced during half-year 2021, including Insilico Medicine’s groundbreaking discovery of a novel target and preclinical drug candidate for Idiopathic Pulmonary Fibrosis (IPF).

The COVID-19 pandemic appears to have been a catalyst for the acceleration of AI adoption by pharmaceutical organizations. This is primarily because of the need to rapidly process vast amounts of data and come up with innovations under strict deadlines. This urgency pushed companies and investors into more opportunistic projects than ever before.

Major financial takeaways regarding AI in the Pharma Industry include the following:

– The COVID–19 pandemic has accelerated the rise of the BioTech and drug discovery sectors generally. During Q1–Q2 2021, we have observed over 50 medium and large funding rounds for BioTech and drug design companies, especially those focused on antiviral therapies and vaccines.

– A number of successful AI-driven companies closed large-sum late-stage venture capital rounds (B, C, and D) in 2021, and several of them are now developing clinical-stage drug candidates. We expect some of them to go public in 2021–2022.

– The first half of 2021 was marked by a notable IPO in the AI-driven drug design space: 3 companies out of 300 under analysis have closed IPOs. Recursion Pharmaceuticals closed its IPO in April and ramped up its IPO target from $100M to $306M. Biomea Fusion and Evaxion Biotech have closed their IPOs and demonstrated solid performance.

– The growing industry traction, reflected in the increasing number of R&D partnerships between big pharma and CROs with AI startups, is a sign that the market is maturing for a rapid increase in M&A activity in the near future.

– Despite the pandemic, publicly traded companies have shown rapid growth, reaching $27.07B of cumulative capitalization as of June 30, 2021.

The data in AI in Pharma Investment Digest is presented and visualized so as to enable strategic decision-makers to extract insights and other valuable, tangible information more easily, with the ultimate aim of optimizing their investment management strategies, assisting and promoting the accelerated growth of AI in the Pharma Industry as a whole.

This Investment Digest is based on the 190-page industry report “AI for Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview Q2 2021,” which provides a comprehensive overview of the pharmaceutical AI sector, including 300 AI in pharma companies, 880 investors, and 100 pharma corporations across the globe.

About Deep Pharma Intelligence
Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries. DPI produces regular analytical reports on major areas of high potential in the pharmaceutical and healthcare industries; maintains ratings of companies and governments based on their innovation potential and business activity in the BioTech space; and provides strategic consulting and investment intelligence services to top-tier clients, including major investment funds and banks, family offices, insurance companies, government organizations, and big pharma companies among others.

About Deep Knowledge Analytics
Deep Knowledge Analytics is a DeepTech-focused agency producing advanced analytics on DeepTech and frontier-technology industries using sophisticated multi-dimensional frameworks and algorithmic methods that combine hundreds of specially-designed and specifically weighted metrics and parameters to deliver insightful market intelligence, pragmatic forecasting, and tangible industry benchmarking.

For press and media inquiries, cooperation, collaboration, and strategic partnership proposals, please contact: info@deep-pharma.tech

Andrii Buvailo
Deep Pharma Intelligence
info@deep-pharma.tech
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

'Kill Zone' Established At Klamath River Dams Shoreline Ecosystem?

A 1911 drawing by famous engineer-dam builder J.C. Boyle clearly depicts that a natural 31-foot-tall dam holding back 'Clammittee Lake' was present at the time construction was begun on Copco 1 dam. This dam had barred fish migration for thousands of year

A 1911 drawing by famous engineer-dam builder J.C. Boyle clearly depicts that a natural 31-foot-tall dam holding back ‘Clammittee Lake’ was present at the time construction was begun on Copco 1 dam. This dam had barred fish migration for thousands of year

Trucks with 'RES' logo parked at Iron Gate Lake during a May 2021 defoliation project

Trucks with ‘RES’ logo parked at Iron Gate Lake during a May 2021 defoliation project

Native plants, gasses and assumably, some animals were decimated with weed-eaters by workers from the trucks bearing the 'RES' logo

Native plants, gasses and assumably, some animals were decimated with weed-eaters by workers from the trucks bearing the ‘RES’ logo

The ground was laid-bare by the workers from trucks bearing the 'RES' logo

The ground was laid-bare by the workers from trucks bearing the ‘RES’ logo

Western Pond Turtles are just one of many rare, threatened and endangered species living in, and around, Copco and Iron Gate Lakes. Baby turtles that require the shoreline for cover and some food, found neither after this reckless defoliation operation

Western Pond Turtles are just one of many rare, threatened and endangered species living-in and around, Copco and Iron Gate Lakes. Baby turtles require the shoreline for cover and some food; they found neither after this reckless defoliation operation

Defoliating native plants at Iron Gate Lake's shoreline ecosystem during the peak period of biological tempo subjected flora and fauna to unreasonable damage

The key premise of 'restoring salmon migration' argued for removing the Klamath River dams by fishing-zealots, is a falsehood and debunked by geology and engineering drawings by J.C. Boyle in 1911”

— William E. Simpson II – Naturalist

YREKA, CALIFORNIA, UNITED STATES, July 29, 2021 /EINPresswire.com/ — One of several critical and compelling arguments for keeping the Klamath River Dams in place, and therefore the freshwater lakes (Copco Lake and Iron Gate Lake), involves protecting the critical habitats for the local threatened and endangered species at the lakes.

Is it possible that there are people who would intentionally impact the species of flora and fauna so as to reduce or eliminate fauna in an area prior to anticipated NEPA compliance via environmental impact report and environmental impact statement?

And if so, what method might be used to reduce species living in and around the freshwater shoreline ecosystem of a lake?

Before we can explore these questions, some background information is required.

Iron Gate and Copco lakes are formed behind two of the four Klamath River dams that some poorly informed people want to remove.

Together, Iron Gate and Copco lakes hold a reserve of 45-Billion gallons of freshwater.

And quite importantly, if these two lakes are drained, the habitats for hundreds of species will be lost, which will result in a major collapse of the web of life, the foundation of which comes from organisms in the lake (including plants and animals), at the water's interface with the land, and shoreline ecosystems.

The interface boundary at water's edge contains a diverse and robust micro-biome that is critical to numerous other lifeforms.

A little known fact is that a large natural lake called 'Clammittee Lake' existed at the current location of Copco Lake for thousands of years.

And over that time, rare and unique flora and fauna co-evolved in and around this natural freshwater lake.

Clammittee Lake as seen in 1911, was formed by a natural 31-foot-tall lava dam about 10,000 years ago, and was holding back the Klamath River in 1911 when the famous engineer and dam builder, J.C. Boyle arrived to build Copco 1 dam.

In fact, the geology of this area (Ward Canyon) shows that over a period of many millions of years, several different lava dams had blocked the Klamath River at one time or another.

One of these naturally-formed lava dams stood 130-feet-tall, holding back the Klamath River into a massive lake that was 1-mile wide and 5-miles long. Over thousands of years, that 130-foot-tall dam eroded, giving control of the river to a smaller, 31-foot-tall lava dam.

Geology and engineering diagrams drawn by J.C. Boyle in 1911, prove that this most recent 31-foot-tall lava dam was effectively holding the waters of the Klamath River into a pristine lake even as construction of Copco 1 dam began.

Nature, not man, had ordained that fish migrations did not pass this 31-foot-tall lava dams, as well as the older larger lava dams.

It's important to note that detailed scientific studies prove that salmon cannot jump higher than 12-feet. Therefore, any dam or barrier higher than about 12-feet-tall would be a significant barrier fish migration.

The Copco 1 dam project began in 1911 and was completed in 1918 under the oversight of the famous engineer and dam builder, J.C. Boyle.

And when the waters from the Klamath River filled-in behind this new 132-foot-tall man-made dam, Clammittee Lake and its smaller dam were covered with water. However, this modern dam was indeed of the same height as the 130-foot-tall prehistoric lava dam, as mentioned.

The important point here is that; millions of years ago, mother Nature built the first dams on the Klamath River, which stood blocking fish passage for time immemorial. Arguably, this barrier (the lava dams) allowed for the allopatric speciation of salmonoids, and the evolutionary rise of the Redband salmonoid, commonly called Redband trout.

The lakes behind the dams, especially Iron Gate Lake and Copco Lake provide habitat for numerous endangered and threatened species of flora and fauna, which arguably have not been properly or objectively assessed beyond out-dated assessments made by contractors hired by same people who benefit the most by dam removal. Such assessments are arguably biased and prejudiced.

The habitat used by the resident rare species of flora and fauna is integral to the shoreline ecosystems of the lakes behind the Klamath River Dams that are being threatened by dam removal.

The 'Kill Zone'

Using weed eaters, people from vehicles marked with the logo of the company called Resource Environmental Solutions, LLC ('RES') defoliated the flora, native and invasive, from large areas of the waterline of Iron Gate Lake.

It has been reported that RES is one of the companies working in cooperation with the shell company, Klamath River Renewal Corporation (KRRC), whose sole mission is to remove the dams, which suggests a predetermined outcome, even before the required NEPA compliance. That is truly concerning!

This defoliation and destruction of habitat began in May of 2021 and continued through June. The defoliation went from the waterline of the lake, back 20 yards onto the lake shore, or more in some areas (See Images).

The flora that was removed has co-evolved fauna, that depend upon these grasses and plants, which were taken down to the dirt.

The question arises; if these people were in fact from RES, did they have a permit, based upon NEPA, to conduct the disturbance of the landscape and arguably the intentional taking of flora and some fauna?

What many people may not realize is the Klamath River Renewal Corporation (KRRC) is paying close attention to the huge flaws in their plan to remove the Klamath River Dams.

More info here: https://www.einpresswire.com/article/546308904/klamath-river-dams-removal-project-defies-logic-and-common-sense-major-flaws-and-misrepresentations-in-plan-revealed

And one of the most glaring flaws in the KRRC plan to remove the Klamath River Dams is the fact that; the existing numerous threatened and endangered species of flora and fauna that require the lakes and shoreline ecosystem will be wiped-out if these lakes are drained to remove the dams.

By removing the shoreline cover native plants and grasses down to the dirt from the water's edge out 20-yards, as it seems that RES has recently done, they have removed the cover that rare species (amphibians, reptiles, birds, small mammals, etc.) require for protection from the sun and predators when they haul-out of the water, or when small terrestrial animals go to the shoreline for a drink.

Without the natural vegetative cover that nature timely provides during springtime, rare species of animals that require the vegetative cover as security for their offspring as well as sources of food, are deprived of that key habitat, and are made exceptionally and unnaturally vulnerable to the host of species of birds and raptors that patrol the lakes and shorelines in search of prey.

Arguably, this defoliation project has led to unnatural depredation of sensitive animal species, some of which are threatened and endangered.

This open area, or what might be called a 'kill zone', has rendering the resident rare and endangered species to rapid and unnatural depredation by predators. And when the birds (and raptors) haul away these rare creatures that have been made vulnerable, there is no evidence left.

The result of creating what can be called a 'kill zone' will inhibit any honest species assessment or verification of the existing threatened and endangered species going forward.

A question arises: Was this by design?

In other words; if the populations of the already rare species of animals suddenly collapse as a result of this defoliation project, which was reckless at the very least, any future objective effort to catalogue and document the presence of existing rare species of fauna during NEPA compliance will be severely hindered, since many of the few remaining rare animals will have been virtually erased for the ecosystem.

When the worker from the truck marked with the 'RES' logo was interviewed, he claimed it was being done to prevent invasive species weeds from being introduced into the lake once it is drained. However, that reply made no sense in light of the millions of seeds from the plants just beyond the 20-yard cut along the shore, and the other 5,000 acres just outside this so called weed boundary?

When the worker was further queried, who via his lexicon surely had some science training, "wasn't this defoliation exposing the threatened and endangered species to abnormal excessive depredation"? The worker replied; "that's a fair assessment".

Navigable waterways in the United States, including the Klamath River and the water and shorelines behind the dams are owned by the public and subject to all of the regulations that require compliance with the National Environmental Policy Act ('NEPA').

Isn't an Environmental Assessment ('EA') and an Environmental Impact Study ('EIS') required for this particular defoliation project, before such a radical disturbance of the habitat required by threatened and endangered species?

What about the Endangered Species Act?

A species is considered endangered if it is in danger of extinction throughout all or a significant portion of its range.

A species is considered threatened if it is likely to become an endangered species within the foreseeable future.

Through federal action and by encouraging the establishment of state programs, the 1973 Endangered Species Act provided for the conservation of ecosystems upon which threatened and endangered species of fish, wildlife, and plants depend.

The Act:

*authorizes the determination and listing of species as endangered and threatened;

*prohibits unauthorized taking, possession, sale, and transport of endangered species;

*provides authority to acquire land for the conservation of listed species, using land and water conservation funds;

*authorizes establishment of cooperative agreements and grants-in-aid to States that establish and maintain active and adequate programs for endangered and threatened wildlife and plants;

*authorizes the assessment of civil and criminal penalties for violating the Act or regulations; and

*authorizes the payment of rewards to anyone furnishing information leading to arrest and conviction for any violation of the Act or any regulation issued thereunder.

William E Simpson
Wild Horse Ranch Productions
+1 858-212-5762
email us here

Western Pond Turtles are endangered….


Source: EIN Presswire

The African Americans in Aviation Traveling Museum Launches Nationwide Tour

Chauncey E. Spencer with attendees at the the EAA Adventure Show

2021 AAA Traveling Museum Tour Map

The museum is important because it creates a bridge for students to learn about aviation history.

Education is important but more important than that is constant education never stopping and always going forward for the betterment of mankind and improving our community.”

— Chauncey E. Spencer II

DIAMOND BAR, CA, UNITED STATES, July 29, 2021 /EINPresswire.com/ — National College Resources Foundation’s partnership with Chauncey E. Spencer II continues to grow the awareness of the contribution of African Americans in Aviation with a three-city summer tour. This traveling museum is significant because it focuses on the life of a pioneer, Chauncey Spencer who fought for racial equality and changed the course of aviation and social history in America. He met with then Senator Harry S. Truman and convinced him to support the inclusion of African Americans in the U. S. Air Force.

“I think this trip is very important, this is the second year that we’ve traveled cross-country and each time we have defined the purpose with success. Education is important but more important than that is constant education, never stopping and always going forward for the betterment of mankind and improving our community,” states Mr. Spencer.

The traveling museum is driven by Chauncey E. Spencer II accompanied by Lavelle DeHughes, NCRF scholarship alum and scholarship recipient at Tuskegee University Institute of Aviation program where he is majoring in Aerospace Science Engineering. He also has the distinction of being chosen as a 2021 Red Tails Scholar. Mr. Spencer is excited to have LaVelle with him knowing he will have the opportunity to share some valuable history of the Tuskegee Airmen that will enhance his journey.

The tour will start out in Oshkosh, Wisconsin at the EAA Adventure Airshow (7/26-8/1); in Chicago, Illinois, it will visit Wendell Phillips Academy High School, Coffey School of Aeronautics, and Dunbar Vocational High School (8/2-8/4); in Detroit, Michigan stops are scheduled at Charles Wright African American Museum and Coleman Young International Airport (8/5–8/7).

As part of NCRF’s S.T.E.A.M. program, the traveling museum exists to inspire students interested in aviation and the Aerospace industry. Dr. Theresa Price comments, “There would be no Tuskegee Airmen, no Red Tails without Mr. Spencer. He paved the way for black pilots and astronauts. We want all to know, young and old, about the history and sacrifices made by the black aviators who were responsible for convincing Congress to include blacks in the pre-World War II Civilian Pilot Training Program.”

NCRF is a 501c3 organization that has created programs and initiatives to provide guidance, resources, information, and pipelines to empower students toward positive post-secondary pursuits. NCRF’s mission is to curtail the high school dropout rate and increase degree and/or certificate enrollment among underserved and underrepresented students. NCRF’s vision is to close the gap in educational achievement, workforce, and economic disparities with the goal to end racism and racial inequality.

Joan Scott
National College Resources Foundation
+1 210-834-9964
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

INNOWELL Announces Single Plug Frac Solution Reducing Completion Times with the Added Benefit of Stronger ESG Profile

Field trial commitments in hand from three mid-sized Permian operators confident that shorter frac stages and real time telemetry will make better wells.

Shorter frac stages make better wells.”

— Senior Completions Engineer, Midsize Permian Producer

HOUSTON, TX, UNITED STATES, July 28, 2021 /EINPresswire.com/ — from the trade floor of the Unconventional Resources Technology Conference / URTeC

INNOWELL introduces its recently patented, next generation plug and perf solution that enhances recovery with pinpoint stage placement while significantly reducing completion costs and total elapsed time on site. The XpressFrac single plug solution also strengthens an organization’s ESG profile (Environmental, Social, Governance) with a dramatically smaller carbon footprint and an approximate 20% reduction in water usage.

INNOWELL’s new solution improves upon the JITP (Just In Time Perforating) process which stimulates multiple single-zone fractures on a single wireline run using perforating guns that remain downhole during the fracturing treatment. JITP was tested on thirty horizontal wells encompassing 1400 single zone treatments; this resulted in substantial cost reduction and productivity uplift because perforation intervals were individually and effectively treated one at a time with less horse power and fewer wireline runs. See IPTC paper 16813.

With many operators now moving toward shorter stage lengths, XpressFrac’s real time telemetry – temperature, pressure and measured depth – enables forward looking operators to quickly and economically implement a custom completion plan for each individual well based on rock properties and other analytics resulting in lowered costs, higher overall EUR (Enhanced Ultimate Recovery) and better reservoir optimization.

About INNOWELL
Founded in 2016 and headquartered in Houston, INNOWELL has been in R&D, prototype, and patent application mode for the last several years. In 2018, INNOWELL was named as one of the “10 Most Promising Companies” from a field of 300+ applicants at the Rice University Alliance Energy and Clean Technology Venture Forum. INNOWELL is currently seeking funding for tool manufacturing in order to complete field trials.

Contact: Bill Pickard
INNOWELL Downhole Technologies, LLC
+1-832-651-6000
bill.pickard@innowelldownhole.com

# # #

Bill Pickard
INNOWELL Downhole Technologies, LLC
+ +1 8326516000
bill.pickard@innowelldownhole.com


Source: EIN Presswire